AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33237965 — intervention group
Group type: EXPERIMENTAL
Intervention: Attachment duration more than four years
Number of subjects: 352
Study 33237965 — intervention group
Group type: EXPERIMENTAL
Intervention: Desire to bear children
Number of subjects: 352
Study 33991085 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for targeted‐therapy related fatigue (CBT‐TTF) delivered via FaceTime for iPad
Number of subjects: 36
Study 33991085 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WLC)
Number of subjects: 36
Study 34174128 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose multi-strain probiotic De Simone formulation (112.5 billion viable lyophilized bacteria per capsule) for 3 months
Number of subjects: 90
Study 34174128 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 33892652 — intervention group
Group type: EXPERIMENTAL
Intervention: Paranasal air suction using a portable air sucker for 120 seconds
Number of subjects: 86
Study 33892652 — intervention group
Group type: COMPARATOR
Intervention: Placebo air suction (no paranasal air suction)
Number of subjects: 86
Study 33892652 — intervention group
Group type: EXPERIMENTAL
Intervention: Paranasal air suction using a portable air sucker
Number of subjects: 86
Study 35858876 — intervention group
Group type: EXPERIMENTAL
Intervention: mNGS
Number of subjects: 440
Study 35858876 — intervention group
Group type: COMPARATOR
Intervention: multiplex PCR followed by mNGS if necessary
Number of subjects: 440
Study 33600826 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP38 infusion (10 pmol/kg/minute)
Number of subjects: 35
Study 33600826 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP38 infusion (10 pmol/kg/minute) followed by sumatriptan (4 mg)
Number of subjects: 35
Study 33600826 — intervention group
Group type: COMPARATOR
Intervention: PACAP38 infusion (10 pmol/kg/minute) followed by placebo (saline)
Number of subjects: 35
Study 35100758 — intervention group
Group type: COMPARATOR
Intervention: Bulb aspirator
Number of subjects: 0
Study 35100758 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal‐oral aspirator
Number of subjects: 0
Study 33465506 — intervention group
Group type: EXPERIMENTAL
Intervention: Real immersive VR environment
Number of subjects: 38
Study 33465506 — intervention group
Group type: COMPARATOR
Intervention: Sham (2D images)
Number of subjects: 38
Study 34865143 — intervention group
Group type: EXPERIMENTAL
Intervention: Daprodustat
Number of subjects: 3872
Study 34865143 — intervention group
Group type: COMPARATOR
Intervention: Darbepoetin alfa
Number of subjects: 3872
Study 34370500 — intervention group
Group type: EXPERIMENTAL
Intervention: Census tract-level disadvantage index score (DIS)
Number of subjects: 444
Study 34370500 — intervention group
Group type: EXPERIMENTAL
Intervention: DIS ≥ 50th percentile (less disadvantage)
Number of subjects: 444
Study 34370500 — intervention group
Group type: EXPERIMENTAL
Intervention: DIS < 50th percentile (more disadvantage)
Number of subjects: 444
Study 33609340 — intervention group
Group type: EXPERIMENTAL
Intervention: Oberstaufen Schrothkur
Number of subjects: 98
Study 33609340 — intervention group
Group type: COMPARATOR
Intervention: diabetes‐friendly holiday
Number of subjects: 98
Study 33774765 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care services (PC)
Number of subjects: 0
Study 33774765 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 0
Study 33846983 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream
Number of subjects: 37
Study 33846983 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine injection
Number of subjects: 37
Study 35034431 — intervention group
Group type: COMPARATOR
Intervention: Corresponding unaffected-ear groups
Number of subjects: 90
Study 34097856 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation (in-hospital oral rivaroxaban 20 mg or 15 mg daily for stable patients, or initial subcutaneous enoxaparin 1 mg/kg twice per day or intravenous unfractionated heparin for clinically unstable patients, followed by rivaroxaban to day 30)
Number of subjects: 615
Study 34097856 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic anticoagulation (standard in-hospital enoxaparin or unfractionated heparin)
Number of subjects: 615
Study 34097856 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation
Number of subjects: 615
Study 34097856 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic anticoagulation
Number of subjects: 615
Study 36100826 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transversus abdominis plane block (TAPB) with 20 mL 0.5% ropivacaine and patient-controlled intravenous analgesia (PCIA)
Number of subjects: 160
Study 36100826 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA) alone
Number of subjects: 160
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with FOLFOX followed by chemoradiation
Number of subjects: 241
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with CP followed by chemoradiation
Number of subjects: 241
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: PET nonresponders who crossed over to CP after induction FOLFOX
Number of subjects: 241
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: PET nonresponders who crossed over to FOLFOX after induction CP
Number of subjects: 241
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: PET responders to induction CP during chemoradiation
Number of subjects: 241
Study 34077237 — intervention group
Group type: EXPERIMENTAL
Intervention: PET nonresponders during chemoradiation
Number of subjects: 241
Study 32448797 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis and cannabinoid-based products (CBP) derived from the cannabis plant
Number of subjects: 0
Study 35932062 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based active case finding (HACF)
Number of subjects: 1076
Study 35932062 — intervention group
Group type: COMPARATOR
Intervention: Telephonic active case finding (TACF)
Number of subjects: 1076
Study 32057433 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-enhanced, semi-skimmed (1.5%) milk
Number of subjects: 712
Study 32057433 — intervention group
Group type: EXPERIMENTAL
Intervention: Fair milk (fair price paid to the milk producers)
Number of subjects: 712
Study 32057433 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% local pasteurized milk (conventional and organic quality)
Number of subjects: 712
Study 32057433 — intervention group
Group type: EXPERIMENTAL
Intervention: All-purpose, long-life, part-skimmed (2.5%) milk
Number of subjects: 712
Study 34473085 — intervention group
Group type: EXPERIMENTAL
Intervention: Fourier shell correlation of two independent maps and phase randomization
Number of subjects: 0
Study 34473085 — intervention group
Group type: EXPERIMENTAL
Intervention: Local resolution estimation and map sharpening techniques
Number of subjects: 0
Study 34473085 — intervention group
Group type: EXPERIMENTAL
Intervention: Map-model comparison using Q-scores and Fourier shell correlation plots
Number of subjects: 0
Study 34473085 — intervention group
Group type: EXPERIMENTAL
Intervention: Annotating the model with B factors
Number of subjects: 0
Study 34473085 — intervention group
Group type: EXPERIMENTAL
Intervention: Detecting and validating water molecules and metal ions in maps
Number of subjects: 0
Study 36137622 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding Persistent Pain (UPP) Digital Decision Aid Tool (DAT)
Number of subjects: 60
Study 36137622 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study 32211953 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild ovarian stimulation (MS) using letrozole/antagonist protocol
Number of subjects: 191
Study 32211953 — intervention group
Group type: COMPARATOR
Intervention: Conventional controlled ovarian stimulation (COS) using high dose gonadotropin (Gn) and GnRH-a stop protocol
Number of subjects: 191
Study 32211953 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild ovarian stimulation (MS)
Number of subjects: 191
Study 32211953 — intervention group
Group type: COMPARATOR
Intervention: Conventional controlled ovarian stimulation (COS)
Number of subjects: 191
Study 35610015 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuzheng Jiedu Xiaoji formula (FJXF) plus TACE
Number of subjects: 0
Study 35610015 — intervention group
Group type: COMPARATOR
Intervention: TACE alone
Number of subjects: 0
Study 35610015 — intervention group
Group type: EXPERIMENTAL
Intervention: FJXF plus TACE
Number of subjects: 0
Study 35610015 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 33045287 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron (25 mg, increased to 50 mg after 4 weeks)
Number of subjects: 706
Study 33045287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 706
Study 32912983 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-Y
Number of subjects: 64
Study 32912983 — intervention group
Group type: EXPERIMENTAL
Intervention: CHU-9D
Number of subjects: 64
Study 32912983 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ-5D-Y and CHU-9D
Number of subjects: 64
Study 35953640 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-pump coronary artery bypass grafting
Number of subjects: 123
Study 35953640 — intervention group
Group type: COMPARATOR
Intervention: On-pump coronary artery bypass grafting
Number of subjects: 123
Study 33185749 — intervention group
Group type: EXPERIMENTAL
Intervention: Impella 2.5/CP
Number of subjects: 423
Study 33185749 — intervention group
Group type: COMPARATOR
Intervention: vaECMO
Number of subjects: 423
Study 33185749 — intervention group
Group type: EXPERIMENTAL
Intervention: Impella 2.5/CP (after adjustment)
Number of subjects: 423
Study 33185749 — intervention group
Group type: COMPARATOR
Intervention: vaECMO (after adjustment)
Number of subjects: 423
Study 35954850 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling-Word Checklist—28 (FWC‐28)
Number of subjects: 62
Study 34274211 — intervention group
Group type: EXPERIMENTAL
Intervention: AIM2ACT intervention (n = 17)
Number of subjects: 33
Study 34274211 — intervention group
Group type: COMPARATOR
Intervention: Self-guided attention control (n = 16)
Number of subjects: 33
Study 33252962 — intervention group
Group type: EXPERIMENTAL
Intervention: LGBT stressors
Number of subjects: 121
Study 33252962 — intervention group
Group type: COMPARATOR
Intervention: General stressors
Number of subjects: 121
Study 35277398 — intervention group
Group type: EXPERIMENTAL
Intervention: Myo-inositol (2 g twice daily until delivery)
Number of subjects: 205
Study 35277398 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 g twice daily until delivery)
Number of subjects: 205
Study 33813110 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (800 mg on day 0 followed by 400 mg per day for 8 days)
Number of subjects: 250
Study 33813110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 33813110 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 250
Study 35584002 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 0
Study 35584002 — intervention group
Group type: COMPARATOR
Intervention: Community weight management intervention
Number of subjects: 0
Study 35584002 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (matched for BMI, age, and sex)
Number of subjects: 0
Study 34549408 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaling essential oil (Lavandula angustifolia 0.1 ml + citrus bergamia 0.1 ml) for 28 days
Number of subjects: 49
Study 34549408 — intervention group
Group type: COMPARATOR
Intervention: Control period (no essential oil) for 28 days
Number of subjects: 49
Study 32600949 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram developed using age at diagnosis, LND, and tumor size
Number of subjects: 717
Study 32600949 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 717
Study 32600949 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group identified by nomogram
Number of subjects: 717
Study 35596886 — intervention group
Group type: EXPERIMENTAL
Intervention: Piranha morcellator
Number of subjects: 210
Study 35596886 — intervention group
Group type: COMPARATOR
Intervention: Versacut morcellator
Number of subjects: 210
Study 35596886 — intervention group
Group type: COMPARATOR
Intervention: Control (Versacut morcellator)
Number of subjects: 210
Study 34254651 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative leaflet (LG)
Number of subjects: 166
Study 34254651 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 166
Study 34254651 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 166
Study 34653425 — intervention group
Group type: EXPERIMENTAL
Intervention: Plenvu (1L polyethylene glycol-based bowel preparation)
Number of subjects: 360
Study 33862467 — intervention group
Group type: EXPERIMENTAL
Intervention: Food addiction explanation for eating behaviours
Number of subjects: 757
Study 33862467 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor dietary and lifestyle choices explanation
Number of subjects: 757
Study 33862467 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI woman
Number of subjects: 757
Study 33862467 — intervention group
Group type: COMPARATOR
Intervention: Lower BMI woman
Number of subjects: 757
Study 34519561 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) 40 mg, oral
Number of subjects: 100
Study 34519561 — intervention group
Group type: COMPARATOR
Intervention: Control procedure (placebo)
Number of subjects: 100
Study 34519561 — intervention group
Group type: EXPERIMENTAL
Intervention: MAST (stress induction)
Number of subjects: 100
Study 34519561 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 100
Study 35869725 — intervention group
Group type: EXPERIMENTAL
Intervention: Baihe gujin decoction and Shengmai powder
Number of subjects: 100
Study 35869725 — intervention group
Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 100
Study 34009348 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-based wound assessment
Number of subjects: 199
Study 34009348 — intervention group
Group type: COMPARATOR
Intervention: Human tracings
Number of subjects: 199
Study 34009348 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-based PGT measurements
Number of subjects: 199
Study 33358942 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 0
Study 33358942 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33915209 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 20
Study 33915209 — intervention group
Group type: COMPARATOR
Intervention: Control Condition (CON)
Number of subjects: 20
Study 35655534 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine + dexmedetomidine (Group R1)
Number of subjects: 97
Study 35655534 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine + dexamethasone (Group R2)
Number of subjects: 97
Study 35655534 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine (Group R)
Number of subjects: 97
Study 33136231 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly nanoparticle albumin‐bound paclitaxel (nab‐PTX)
Number of subjects: 303
Study 33136231 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly solvent‐based paclitaxel (Sb‐PTX)
Number of subjects: 303
Study 34736731 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban monotherapy
Number of subjects: 2215
Study 34736731 — intervention group
Group type: COMPARATOR
Intervention: Rivaroxaban plus antiplatelet therapy
Number of subjects: 2215
Study 32062444 — intervention group
Group type: EXPERIMENTAL
Intervention: fampridine‐MR 10 mg bd
Number of subjects: 40
Study 32062444 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study 35986415 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep-Opt intervention (technology-assisted behavioral sleep intervention)
Number of subjects: 120
Study 35986415 — intervention group
Group type: COMPARATOR
Intervention: Healthy living attention control group
Number of subjects: 120
Study 33478179 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized oral health education program in combination with routine dental care
Number of subjects: 579
Study 33478179 — intervention group
Group type: COMPARATOR
Intervention: Routine dental care
Number of subjects: 579
Study 33478179 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized oral health education program
Number of subjects: 579
Study 32270639 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment group (acupuncture at the 'thirteen ghost points' and kaixin powder)
Number of subjects: 60
Study 32270639 — intervention group
Group type: COMPARATOR
Intervention: Chinese medication group (kaixin powder only)
Number of subjects: 60
Study 35500910 — intervention group
Group type: EXPERIMENTAL
Intervention: Skiing (active skiing for at least 2 years)
Number of subjects: 68
Study 33485159 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cooperative Class (GCC)
Number of subjects: 99
Study 33485159 — intervention group
Group type: COMPARATOR
Intervention: Conventional Class (CC)
Number of subjects: 99
Study 35303014 — intervention group
Group type: EXPERIMENTAL
Intervention: IC+CCRT
Number of subjects: 0
Study 35303014 — intervention group
Group type: COMPARATOR
Intervention: CCRT
Number of subjects: 0
Study 35303014 — intervention group
Group type: COMPARATOR
Intervention: CCRT+AC
Number of subjects: 0
Study 33300039 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased nut consumption (almonds, pistachios, walnuts, and other nuts)
Number of subjects: 5800
Study 33300039 — intervention group
Group type: EXPERIMENTAL
Intervention: Tertiles of change in nut consumption
Number of subjects: 5800
Study 35089159 — intervention group
Group type: EXPERIMENTAL
Intervention: Step-based goals (7000-10,000 steps/day)
Number of subjects: 212
Study 35089159 — intervention group
Group type: EXPERIMENTAL
Intervention: Minute-based goals (50-200 minutes/week)
Number of subjects: 212
Study 35089159 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition probability for minute-based goals during graded goal phase
Number of subjects: 212
Study 35089159 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition probability for step-based goals during graded goal phase
Number of subjects: 212
Study 35089159 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition probability for minute-based goals during fixed goal phase
Number of subjects: 212
Study 35089159 — intervention group
Group type: EXPERIMENTAL
Intervention: Transition probability for step-based goals during fixed goal phase
Number of subjects: 212
Study 34148803 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 605
Study 34148803 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 605
Study 32800909 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 146
Study 32800909 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 146
Study 92313688 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin 400 mg/24 h for 7 days (Group I)
Number of subjects: 15
Study 92313688 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin 400 mg/12 h for 7 days (Group II)
Number of subjects: 15
Study 36072904 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoplasmic reticulum stress-related differentially expressed genes (DEGs) identified through machine learning methods.
Number of subjects: 0
Study 36072904 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis of potential biomarkers with immune cell infiltration.
Number of subjects: 0
Study 33562015 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to dietary targets (≥1 target achieved)
Number of subjects: 549
Study 33562015 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to dietary targets (≥2 targets achieved)
Number of subjects: 549
Study 35966022 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (CrM) supplementation (0.1 g·kg‐1·day‐1)
Number of subjects: 23
Study 35966022 — intervention group
Group type: COMPARATOR
Intervention: Non-supplemented control group (CON)
Number of subjects: 23
Study 33131908 — intervention group
Group type: EXPERIMENTAL
Intervention: 320 mg/day anthocyanins
Number of subjects: 176
Study 33105381 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP one-repetition maximum warm-up (RMWU) after standard warm-up (SWU)
Number of subjects: 0
Study 33105381 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP eccentric flywheel warm-up (EWU) after standard warm-up (SWU)
Number of subjects: 0
Study 33105381 — intervention group
Group type: COMPARATOR
Intervention: Standard warm-up (SWU)
Number of subjects: 0
Study 33105381 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP one-repetition maximum warm-up (RMWU)
Number of subjects: 0
Study 35778960 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ondansetron
Number of subjects: 46
Study 35778960 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 46
Study 34128908 — intervention group
Group type: EXPERIMENTAL
Intervention: Avocado-based Mediterranean diet with intake of 1/2 portion of Avocado per day
Number of subjects: 200
Study 34128908 — intervention group
Group type: COMPARATOR
Intervention: Low-fat high-complex carbohydrate diet
Number of subjects: 200
Study 34128908 — intervention group
Group type: EXPERIMENTAL
Intervention: Avocado-based Mediterranean diet
Number of subjects: 200
Study 35192711 — intervention group
Group type: EXPERIMENTAL
Intervention: Polar Life Pod (PLP)
Number of subjects: 13
Study 35192711 — intervention group
Group type: COMPARATOR
Intervention: Stationary tubs (TUB)
Number of subjects: 13
Study 33593886 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant PD-L1 inhibition in combination with chemotherapy
Number of subjects: 162
Study 33593886 — intervention group
Group type: EXPERIMENTAL
Intervention: Durvalumab arm
Number of subjects: 162
Study 33593886 — intervention group
Group type: COMPARATOR
Intervention: Placebo arm
Number of subjects: 162
Study 33593886 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms
Number of subjects: 162
Study 33593886 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory analysis
Number of subjects: 162